Company / Income Tax
BIOCRYST PHARMACEUTICALS INC Income Tax History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$3.5M
FY2025
5-year range
$310.0K / $3.5M
FY2021-FY2025
Trend
+83.2%
vs FY2024
Sector context
#56 of 204
Health Care
What the data says
At $4M, BIOCRYST PHARMACEUTICALS INC's income tax ranks #149 of 204 in the Health Care sector. Increased from $310,000 to $4M over the past 2 years.
Based on SEC 10-K filings.
$4M in FY2025 with a 3-year CAGR of +8.9%.
Increased from $310,000 to $4M over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- +8.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#149 of 204 in Health CareTop 73% of 204This company $3.5M Sector average $118.7M
▼
-97.0% below sector average
Key checks
Key Insights
- 3-year CAGR of +8.9%, indicating consistent growth.
- In FY2025, income tax increased 83.2% year-over-year.
- Ranks #56 out of 204 companies in the Health Care sector.
- Lowest income tax in the period was in FY2020.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.5M | +83.2% |
| FY2024 | $1.9M | +521.6% |
| FY2023 | $310.0K | -88.7% |
| FY2022 | $2.7M | +21.3% |
| FY2021 | $2.3M | - |
| FY2020 | $0 | - |
| FY2019 | $0 | - |
| FY2018 | $0 | - |
| FY2017 | $0 | - |
| FY2016 | $0 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026